首页|清化益胃汤结合气交灸对脾虚气滞血瘀证慢性萎缩性胃炎患者幽门螺杆菌根除率及Musashi-1 mRNA表达的影响

清化益胃汤结合气交灸对脾虚气滞血瘀证慢性萎缩性胃炎患者幽门螺杆菌根除率及Musashi-1 mRNA表达的影响

扫码查看
目的 探讨清化益胃汤结合气交灸对脾虚气滞血瘀证慢性萎缩性胃炎(CAG)患者幽门螺杆菌(H。pylori)根除率及Musashi-1 mRNA表达的影响,为该类患者的治疗提供参考。方法 选取我院2022年1月至2023年10月收治的200例CAG患者为研究对象。入选患者按照随机对照原则分为4个组,均50例,其中对照组接受标准幽门螺杆菌四联疗法治疗,观察1组在对照组基础上予以清化益胃汤,观察2组在对照组基础上予以气交灸,观察3组在对照组基础上予以清化益胃汤联合气交灸。对比四组患者临床疗效、炎症因子水平、Musashi-1 mRNA表达水平、H。pylori清除率及生活质量。结果 治疗后,观察3组患者总有效率(92。00%)最高。治疗后四组患者白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平均降低,血清胃泌素-17(G17)水平均升高;观察3组患者IL-6、TNF-α水平均低于对照组、观察1组和观察2组,G17水平高于对照组、观察1组和观察2组(均P<0。05)。治疗后四组患者Musashi-1 mRNA表达水平均降低,其中观察3组低于对照组、观察1组和观察2组(F=4。551,P<0。05)。治疗后观察3组患者H。pylori清除率(92。00%)高于对照组(74。00%)、观察 1 组(76。00%)和观察 2 组(78。00%)(x2=4。204,P<0。05)。治疗后,四组患者生活质量水平均提升,其中观察3组生活质量评分高于对照组、观察1组和观察2组高(均P<0。05)。结论 清化益胃汤结合气交灸能抑制脾虚气滞血瘀证慢性萎缩性胃炎患者Musashi-1 mRNA表达,提升H。pylori根除率和生活质量,降低炎症反应,疗效显著。
Effects of Qinghua Yiwei Decoction combined with Qijiao moxibustion on Helicobacter pylori eradication rate and Musashi-1 mRNA expression in chronic atrophic gastritis with spleen deficiency Qi stagnation and blood stasis syndrome
Objective To observe the effects of Qinghua Yiwei Decoction combined with Qijiao moxibustion on Helico-bacter pylori(H.pylori)eradication rate and Musashi-1 mRNA expression in patients with chronic atrophic gastritis(CAG)of spleen deficiency Qi stagnation and blood stasis,providing a reference for the treatment.Methods A total of 200 pa-tients with CAG treated in our hospital from January 2022 to October 2023 were enrolled and randomly divided into 4 groups(n=50),receiving standard H.pylori quadruple therapy;additionally,based on this,the observation group 1 re-ceived Qinghua Yiwei Decoction,observation group 2 received Qijiao moxibustion,and observation group 3 received Qinghua Yiwei Decoction combined with Qijiao moxibustion.The clinical efficacy,inflammation level,Musashi-1 mRNA expression level,H.pylori eradication rate and quality of life were compared among the 4 groups.Results After treat-ment,the total efficiency rate in the observation group 3(92.00%)was the highest.In the 4 groups,the levels of interleukin-6(IL-6)and tumor necrosis factor α(TNF-α)decreased,and serum gastrin-17(G17)level increased.The levels of IL-6 and TNF-α in observation group 3 were lower,while G17 level was higher than in the control group,observation group 1 and observation group 2,respectively(all P<0.05).After treatment,Musashi-1 mRNA expression level decreased in all groups,while that in the observation group 3 was lower than in the control group,observation group 1 and observation group 2,respectively(F=4.551,P<0.05).H.pylori eradication rate in observation group 3(92.00%)was higher than in control group(74.00%),observation group 1(76.00%),and observation group 2(78.00%)resepctively(x2=4.204,P<0.05).After treatment,the quality of life in the four groups was improved,and that in the observation group 3 was high-er than in the control group,observation group 1 and observation group 2,respectively(all P<0.05).Conclusion Qinghua Yiwei Decoction combined with Qijiao moxibustion can inhibit the expression of Musashi-1 mRNA in chronic atrophic gastritis patients with spleen deficiency Qi stagnation and blood stasis syndrome,improve the eradication rate of H.pylori and quality of life,and reduce the inflammatory response,with significant effect.

Qinghua Yiwei DecoctionQijiao moxibustionChronic atrophic gastritisSpleen deficiency Qi stagnation and blood stasisHelicobacter pylori

陈淑婉、吴小莹、傅燕虹、王丽斯

展开 >

佛山市第一人民医院中西医结合科,广东 528000

佛山市顺德区乐从医院检验科

清化益胃汤 气交灸 慢性萎缩性胃炎 脾虚气滞血瘀证 幽门螺杆菌

2024

中国微生态学杂志
中华预防医学会 大连医科大学

中国微生态学杂志

CSTPCD北大核心
影响因子:1.115
ISSN:1005-376X
年,卷(期):2024.36(11)